Trial intelligence / Profile preview

Reaction Time Monitored Patient Maintained Propofol Sedation

NCT00321360Phase 4Completed

Start
May 2006
Primary completion
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol in Procedural sedation (PS). Primary endpoints: Minimal Sedation Level (modified Objective Observer's Assessment of Sedation) and Maximal change in oxygen saturation (SpO2). Started May 2006; status: completed.

02

Drugs

propofol
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT00321360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00321360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call